ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer. The Company seeks to improve the performance and commercial potential of existing treatments by addressing problems associated with these treatment regimens.
ADVENTRX Pharmaceuticals – Acquired by Mast Therapeutics (AMEX) in 2007 (1.5x multiple)Arash Sani2021-09-12T09:06:02-08:00